Register entry
- Registered sites
- 0
- Active NDC listings
- 7
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
77 active NDC listings: 6 bulk ingredient, 1 drug for further processing. By marketing category: BULK INGREDIENT 6, DRUG FOR FURTHER PROCESSING 1.
| Dosage form | NDCs |
|---|---|
| powder | 6 |
| injection, suspension | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| cilag ag | 7 |
Catalogue
Marketed products
7| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Alcaftadine | powder | 12502-5263BULK INGREDIENT |
| - | Cladribine | powder | 12502-4912BULK INGREDIENT |
| - | Cladribine | powder | 12502-5406BULK INGREDIENT |
| - | Erdafitinib | powder | 12502-6848BULK INGREDIENT |
| - | Remifentanil hydrochloride | powder | 12502-5343BULK INGREDIENT |
| - | bortezomib | powder | 12502-5268BULK INGREDIENT |
| - | rilpivirine hydrochloride | injection, suspension | 12502-5500DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing cladribine
- EMD Serono, Inc.12 sites · 18 NDC
- MSN Laboratories Private Limited,8 sites · 275 NDC
- Apotex Inc.6 sites · 372 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
- Sionc Pharmaceuticals Private Limited2 sites · 56 NDC
- ScinoPharm Taiwan, Ltd.1 site · 87 NDC
- Reliable Biopharmaceutical, LLC1 site · 33 NDC
- Genvion Corporation1 site · 4 NDC
Enquiry
Common questions
- Is Cilag AG FDA approved?
- Cilag AG holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Cilag AG make?
- 7 products are listed under Cilag AG in the openFDA NDC Directory, most often as powder; injection, suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.